Dysimmunity in common variable immunodeficiency is associated with alterations in oral, respiratory, and intestinal microbiota

• Published in: Clinical immunology (Orlando, Fla.) Fla.), 2023-11, Vol.256, p.109796-109796, Article 109796
• Main Authors: Cabanero-Navalon, Marta Dafne, Garcia-Bustos, Victor, Mira, Alex, Moral Moral, Pedro, Salavert-Lleti, Miguel, Forner Giner, María José, Núñez Beltrán, María, Todolí Parra, José, Bracke, Carme, Carda-Diéguez, Miguel
• Format: Article
• Language: English
• Subjects: Autoimmunity; Common variable immunodeficiency; CVID; Immune dysregulation; Microbiome; Microbiota
• ISSN: 1521-6616; 1521-7035
• DOI: 10.1016/j.clim.2023.109796

Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency characterized by decreased immunoglobulins and recurrent infections. Its aetiology remains unknown, and some patients present with severe non-infectious autoimmune or inflammatory complications with elevated associated morbimortality. Recently, intestinal dysbiosis has been proposed as a driver of immune dysregulation. In this study, we assessed the oral, respiratory, and gastrointestinal microbiota of 41 CVID patients (24 with dysimmune and 17 with infection complications) and 15 healthy volunteers using 16S rRNA gene sequencing to explore associations between microbiome profiles and CVID phenotypes. Profound differences in the composition of the microbiota in saliva, sputum, and stool were detected between dysimmune CVID patients and healthy individuals. Globally, respiratory species diversity and faecal bacterial richness were lower in CVID individuals with immune complications. Although a single species could not be identified as a robust predictor of dysimmunity, a combination of around 5–7 bacterial species in each type of sample could predict this severe phenotype with an accuracy of around 90% in the study population. Our study provides new insights into these previously unexplored but highly interrelated ecological niches among themselves and with patient profiles. Our data suggest that this disease-related systemic dysbiosis could be implicated in the immune dysregulation associated with severe cases of CVID. •Dysimmune CVID phenotypes own deep microbial differences in saliva, sputum and faeces.•A combination of several bacteria can predict dysimmunity in CVID.•An altered microbiome might trigger abnormal immune responses in CVID.